Hepatic vein thrombosis (Budd-Chiari syndrome)

Seminars in Liver Disease

Volumn 22, Issue 1, 2002, Pages 5-14

  Valla, Dominique Charles ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Angioplasty; Hepatic vein thrombosis; Portosystemic shunt; Thrombogenic disorders; Transplantation

Indexed keywords

ANTICOAGULANT AGENT; DIURETIC AGENT; HEPARIN;

ANTICOAGULATION; ASCITES; BUDD CHIARI SYNDROME; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; GASTROINTESTINAL HEMORRHAGE; HISTOPATHOLOGY; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; LIVER VEIN THROMBOSIS; MYELOPROLIFERATIVE DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCORING SYSTEM; SURVIVAL RATE;

EID: 0036124980     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-23202     Document Type: Review

References (84)

1. Veno-occlusive disease of the liver
2. Occlusion of the hepatic veins in man
3. Centrilobular and perisinusoidal fibrosis in experimental congestive liver in the rat
4. Lymph imbalance in the genesis and perpetuation of the ascites syndrome in hepatic cirrhosis
5. Mesoatrial shunt hemodynamics
6. Budd-Chiari syndrome: MR evaluation
7. Budd-Chiari syndrome: Imaging with pathologic correlation
8. MRI of Budd-Chiari syndrome
9. Oxidative stress produced by suprahepatic occlusion and reperfusion
10. Ischemia/reperfusion injury of the liver: Pathophysiologic hypotheses and potential relevance to human hypoxic hepatitis
11. Pathology of the liver in Budd-Chiari syndrome: Portal vein thrombosis and the histogenesis of veno-centric cirrhosis, veno-portal cirrhosis, and large regenerative nodules
12. Hepatic nodules in Budd-Chiari syndrome: Imaging features
13. Poor prognosis and limited therapeutic options in patients with BuddChiari syndrome and portal venous system thrombosis
14. Comparison of ultrasonography, computed tomography and 99mTc liver scan in diagnosis of Budd-Chiari syndrome
15. The Budd-Chiari syndrome: Correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction
16. Collateral channels and histopathology in hepatic vein occlusion
17. The changing scene of hepatic vein thrombosis: Recognition of asymptomatic cases
18. Flow cytometric analysis of autonomous growth of erythroid precursors in liquid culture detects occult polycythemia vera in the Budd-Chlari syndrome
19. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: Results of a case-control study
20. Cause of portal or hepatic venous thrombosis in adults: The role of multiple concurrent factors
21. Clinical spectrum, investigations and treatment of Budd-Chiari syndrome
22. Vascular-bed-specific hemostasis and hypercoagulable states
23. Venous thrombosis: A multicausal disease
24. Hypercoagulable states: Molecular genetics to clinical practice
25. Factor V Leiden-related Budd-Chiari syndrome
26. Budd-Chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases
27. Hepatic vascular disease and portal hypertension in polycythemia vera and agnogenic myeloid metaplasia: A clinicopathological study of 145 patients examined at autopsy
28. Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome
29. Formes frustes in myeloproliferative disorders. Identification by the growth of an endogenous erythroid clone in vitro in patients with arterial vascular disease
30. Natural history of paroxysmal nocturnal hemoglobinuria
31. Paroxysmal nocturnal haemoglobinuria: Long-term follow-up and prognostic factors
32. Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome
33. Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome
34. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis
35. Factor V Leiden mutation and the risks for thromboembolic disease: A clinical perspective
36. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study
37. Drug-induced vascular and sinusoidal lesions of the liver
38. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature
39. Obstruction of the hepatic veins or suprahepatic inferior vena cava
40. Hepatic vein thrombosis in Behcet's disease
41. Recovery from hepatic vein thrombosis (Budd-Chiari syndrome) complicating ulcerative colitis
42. Association of hepatic vein obstruction and coeliac disease in North African subjects
43. Hepatic vein obstruction - A retrospective analysis of 72 autopsies and biopsies
44. Budd-Chiari syndrome: Long-term survival and factors affecting mortality
45. Hepatic venous outflow obstruction in patients with polycystic liver disease: Pathogenesis and treatment
46. Selective surgical therapy of the Budd-Chiari syndrome provides superior survivor rates than conservative medical management
47. Hepatic venous outflow block caused by short-length hepatic vein stenoses
48. Proposal of a new nomenclature for Budd-Chiari syndrome: Hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion
49. Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome
50. Outcome of Budd-Chiari syndrome: A multivariate analysis of factors related to survival including surgical portosystemic shunting
51. Vascular radiology in the Budd-Chiari syndrome
52. Direct transhepatic assessment of hepatic vein pressure and direction of flow using a thin needle in patients with cirrhosis and Budd-Chiari syndrome. An effective alternative to hepatic vein catheterization
53. Budd-Chiari syndrome: Value of duplex sonography and colour Doppler imaging for diagnosis and follow-up
54. Analysis of hepatic vein waveform by Doppler ultrasonography in 100 patients with portal hypertension
55. Color Doppler imaging findings in patients with Budd-Chiari syndrome: Correlation with venographic findings
56. Budd-Chiari syndrome
57. Classification of hepatic venous outflow obstruction: Ambiguous terminology of the Budd-Chiari syndrome
58. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis)
59. Hepatic and portal vein thrombosis in cirrhosis: Possible role in development of parenchymal extinction and portal hypertension
60. Diagnosis of cirrhosis based on regional changes in hepatic morphology. A radiological and pathological analysis
61. Portal thrombosis: Dynamic CT features and course
62. Reassessing the role of medical therapy in the management of hepatic vein thrombosis
63. Hepatic transplantation with perioperative and long term anticoagulation as treatment for Budd-Chiari syndrome
64. Porto-hepatic thrombosis, revealing paroxysmal nocturnal hemoglobinuria, followed by regression induced by heparin therapy
65. A lethal complication of peripheral vein vasopressin infusion
66. Managing Budd-Chiari syndrome: A retrospective review of percutaneous hepatic vein angioplasty and surgical shunting
67. Tissue plasminogen activator for hepatic vein thrombosis in paroxysmal nocturnal haemoglobinuria
68. Interventional therapeutic techniques in Budd-Chiari syndrome
69. Expandable venous stents for treatment of the Budd-Chiari syndrome
70. Surgical and radiologic treatment of primary Budd-Chiari syndrome
71. Dorsocranial liver resection and direct hepatoatrial anastomosis for hepatic venous outflow obstruction: Long-term outcome and functional results
72. Surgical options, hematologic evaluation, and pathologic changes in Budd-Chiari syndrome
73. Management of hepatic venous outflow obstruction
74. Treatment of Budd-Chiari syndrome by side-to-side portacaval shunt: Experimental and clinical results
75. Portosystemic shunt versus orthotopic liver transplantation for the Budd-Chiari syndrome
76. Results of portal systemic shunts in Budd-Chiari syndrome
77. Portosystemic shunt in Budd-Chiari syndrome: Long-term survival and factors affecting shunt patency in 25 patients in Western countries
78. Budd-Chiari syndrome associated with chronic myeloproliferative syndromes: Analysis of 6 cases
79. Budd-Chiari syndrome: Technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt
80. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: Review of indications and problems
81. Successful emergency treatment with a transjugular intrahepatic portosystemic shunt for life-threatening Budd-Chiari syndrome with portal thrombotic obstruction
82. Which is the best surgery for Budd-Chiari syndrome: Venous decompression or liver transplantation? A single-center experience with 50 patients
83. Liver transplantation for the Budd-Chiari syndrome
84. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplanation